Immunogenicity of a BNT162b2 vaccine booster in health-care workers
Lancet Microbe
.
2021 Dec;2(12):e650.
doi: 10.1016/S2666-5247(21)00272-X.
Epub 2021 Oct 11.
Authors
Esther Saiag
1
,
Hanoch Goldshmidt
2
,
Eli Sprecher
3
,
Ronen Ben-Ami
4
,
David Bomze
3
Affiliations
1
Department of Information Systems and Operations, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
2
Division of Clinical Laboratories, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
3
Division of Dermatology, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
4
Department of Infectious Diseases and Infection Control, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
PMID:
34661180
PMCID:
PMC8504922
DOI:
10.1016/S2666-5247(21)00272-X
No abstract available
Publication types
Letter
MeSH terms
BNT162 Vaccine*
COVID-19 Vaccines / therapeutic use
Humans
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
BNT162 Vaccine